References

  1. Andersen MH, Pedersen LØ, Capeller B, Bröcker E-B, Becker JB, thor Straten P (2001)
    Spontaneous cytotoxic T-cell responses against Survivin-derived MHC class I-restricted T-cell epitopes in Situ as well as ex vivo in cancer patients
    Cancer Res, Aug, 61,5964-68
  2. Schrama D, Pedersen LØ, Keikavoussi P, Andersen MH, Straten Pt, Bröcker E-B, Kämpgen E Becker JC , (2002)
    Aggregation of Antigen-Specific T Cells at the Inoculation Site of Mature Dendritic Cells
    J Invest Dermatol 119:1443-48
  3. Schrama D, Eggert AAO, Bröcker E-B, Pedersen LØ, Straten Pt, Becker JC (2003)
    Immunological consequences of the sentinel lymph-node biopsy-lessons from a melanoma patient
    Lancet Oncol 4:446-47
  4. Andersen MH, Reker S, Becker JC, Straten Pt (2004)
    The Melanoma Inhibitor of Apoptosis Protein: A Target for Spontaneous Cytotoxic T Cell Response
    J Invest Dermatol 122:392-399
  5. Berger TG, Haendle I, Schrama D, Lüftl M, Bauer N, Pedersen LØ, Schuler-Thurner B, Hohenberger W, thor Straten P, Schuler G, Becker JC (2004)
    Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocytes-derived dendritic cells
    Int J Cancer 111,229-37
  6. Otto K, Andersen MH, Eggert A, Keikavoussi P, Pedersen LØ, Rath JC, Böck M, Bröcker E-B, thor Straten P, Kämpgen E, Becker JC (2005)
    Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen surviving
    Vaccine Jan4;23(7)884-9
  7. Thor Straten P, Dahl C, Schrama D, Pedersen LØ, Andersen MH, Seremet T, Bröcker E-B, Guldberg P, Becker JC (2006)
    Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes
    Cancer Immunol Immunother May;4(5)399-409
  8. Storm P, Bartholdy C, Sørensen MR, Christensen JP, Thomsen AR (2006)
    Perforin-deficient CD8+ T cells mediate fatal lymphocytic choriomeningitis despite Impaired cytokine production
    J Virol Feb 80(3)1222-1230
  9. Hadrup SR, Strindhall J, Køllgaard T, Johansson B, Pawelec G, thor Straten P, Wikby A (2006)
    Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional CMV specific T cells in the very elderly.
    J Immunol (Feb) 176(4)1645-53
  10. Batard P, Peterson DA, Devevre E, Guillaume P, Cerottini J-C, Rimoldi D, Speiser DE, Winther L, Romero P (2006)
    Dextramers: New generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8 T cells.
    J Immunol Methods March 20;310(1-2)136-48
  11. Christensen JE, de Lemos C, Moos T, Christensen JP and Thomsen AR (2006)
    CXCL10 is the key ligand for CXCR3 on CD8+ effector T-cells involved in immune surveillance of the LCMV-infected CNS.
    J Immunol Apr 176(7):4235-43
  12. Hadrup SR, Gehl J, Sørensen RB, Geertsen P, thor Straten P, Andersen MH (2006)
    Persistence of survivin specific T cells for seven years in a malignant melanoma patient during complete remission.
    Cancer Biol Ther May 5:5, 480-2
  13. Sorensen RB, Hadrup SR, Kollgaard T, Svane IM, Thor Straten P, Andersen MH (2006)
    Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patient.
    Cancer Immunol Immunother Apr;56(4)527-33
  14. Poulsen LH, Jacobsen K, Storie I, Jakobsen T, Laursen J (2006)
    High-speed quantitation of CMV specific cytotoxic T-cells in whole blood
    MASIR Meeting June 2006, Abstract#P74
  15. Hadrup SR, Braendstrup O, Jacobsen GK, Mortensen S, Pedersen LO, Seremet T, Andersen MH, Becker JC, Straten PT (2006)
    Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells.
    Int J Cancer 2006 Aug 15;119(4):831-8
  16. Gupta AJ, Leung E, Mi H, Carter V, Anand V, Chatopadhyay, Shenton B, Kirby J, Talbot D (2006)
    Assessment of variation in Epstein-Barr virus specific T cells following transplantation using MHC class I-peptide complexes (Abstract)
    Transplantation Suppl. Abstract #253 (PO-151) www.wtc2006.org
  17. Svane IM, Pedersen AE, Johnsen HE, Nielsen D, Kamby C, Nikolajsen S, Ottesen S, Zocca M, Johansen JS, Claesson MH (2006)
    Dendritic cells loaded with wild-type p53 peptides induce T cell immunity and disease stabilization in patients with advanced breast cancer (Abstract)
    J Clin Oncol 24(18Suppl)June, 2577
  18. Houtenbos I, Westers TM, Dijkhuis A, de Gruijl TD, Ossenkoppele GJ, van de Loosdrecht AA (2007)
    Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.
    Clin Cancer Res Jan1;13(1)307-15
  19. Bartholdy C, Kauffmann SO, Christensen JP Thomsen AR (2007)
    Agonistic anti CD-40 antibody profoundly suppresses the immune response to infection with lymphocytic chriomeningitis virus.
    J Immunol 178:1662-1670
  20. Holst PJ, Bartholdy C, Stryhn A, Thomsen AR, Christensen JP (2007)
    Rapid and sustained CD4+ T-cell-independent immunity from adenovirus-encoded vaccine antigens
    J Gen Virol 88 (in press)
  21. Holst PJ, Orskov C, Qvortrup K, Christensen JP, Thomsen AR (2007)
    CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated Hepatic Steatosis
    J Virol, Sept 2007, 10101-10112.

Products and support
If you need information concerning Immudex products, have a technical enquiry, or are interested in customer-defined Dextramers and/or collaboration with Immudex, please contact us on Email customer@immudex.com
If you need ordering information, please contact on us Email ordering@immudex.com